Ann: General Meeting Dial-In Details, page-76

First 76 Last

Share
Profile

Follow
$tockfella

3,151 Posts.

1293

19/03/20

20:24

Post #: 43592299
Share

Originally posted by pj had: ↑

Thanks huwscor,

I was one of the five in person at the meeting and asked Yacov some questions.

You picked up a lot of the conversations. Some more / different notes of mine are below.

The Prizma ($72 to GMV of $127 from Medicare) is for ongoing everyday monitoring, where as the Patch ($315? holter and $750?MCT) is for in hospital and post discharge over a period up to 14 days?

They give the Patch away for free; it’s all about recurring revenue from monitoring.

China, they submitted for emergency approval to 5 provinces, in addition to their national application 5 weeks ago.

The clinical trial results are being compiled by the independent CRO who will submit the dossier. Although Yacov suggested the results are ‘better than gold standard’ they probably won’t be shared publicly, at least not until after the device is cleared.

UK trials are slow, discussions have been held with distribution companies across UK (not US?), so to not ‘burn cash’ on one person. My guess is they would seek to have something similar to the Italy set up.

US IDTF bought in 2017 mainly for their 200 insurance agreements, which would have been 5 years to build if not bought. Although the high growth rate last year was mainly due to the Telerythmics purchase in late 2018, I have more confidence after today that the growth rates will continue to be healthy as more providers are signed up, just an opinion.

US FDA asked for anti defibrillate circuit during their reviews of the Patch, that required a redesign to their latest ‘requirements’, so it sounds feasible that it will be one of the most advanced ‘patches’ on the market when it eventually gets approved.

Australia is on the radar only because the government recently indicated reimbursement for Telehealth consultations could be on the agenda.

Expand

How does the $72 US rebate work exactly? Wonder if we can make some projections on this? Appears to me that from what today's attendees have to report, is that recurring revenue in USA will be increased not only in new patients being monitored, but also in these new rebates from Medicare? Or is the US Govt? Confused..

GMV Price at posting: 4.5¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

C29

C29 Metals wins Kazakhstani uranium drill run green tick, Kazatomprom talks mature

QHL

Aerospace smallcap Quickstep Holdings jumps nearly 100% after 40cps takeover offer

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

PFE

Pantera begins drilling of maiden test well at Smackover

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

There are more pages in this discussion • 29 more messages in this thread...

First 76 Last

Add GMV (ASX) to my watchlist

Ann: General Meeting Dial-In Details, page-76

Top Stories

C29 Metals wins Kazakhstani uranium drill run green tick, Kazatomprom talks mature

Aerospace smallcap Quickstep Holdings jumps nearly 100% after 40cps takeover offer

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Pantera begins drilling of maiden test well at Smackover

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Featured News